TAZEMETOSTAT HYDROBROMIDE for Soft tissue sarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 298 adverse event reports in the FDA FAERS database where TAZEMETOSTAT HYDROBROMIDE was used for Soft tissue sarcoma.
Most Reported Side Effects for TAZEMETOSTAT HYDROBROMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 298 | 22.5% | 60 | 48 |
| Fatigue | 292 | 22.1% | 10 | 41 |
| Disease progression | 267 | 20.2% | 44 | 44 |
| Nausea | 207 | 15.7% | 12 | 31 |
| Product dose omission issue | 183 | 13.8% | 4 | 32 |
| Death | 106 | 8.0% | 105 | 27 |
| Diarrhoea | 100 | 7.6% | 2 | 11 |
| Decreased appetite | 81 | 6.1% | 4 | 17 |
| Asthenia | 75 | 5.7% | 5 | 29 |
| Vomiting | 75 | 5.7% | 8 | 16 |
| Constipation | 66 | 5.0% | 2 | 5 |
| Covid-19 | 65 | 4.9% | 4 | 30 |
| Alopecia | 61 | 4.6% | 2 | 8 |
| Headache | 61 | 4.6% | 3 | 5 |
| Pain | 58 | 4.4% | 5 | 17 |
Other Indications for TAZEMETOSTAT HYDROBROMIDE
Follicular lymphoma (439)
Off label use (102)
B-cell lymphoma (91)
Malignant connective tissue neoplasm (72)
Product used for unknown indication (54)
Epithelioid sarcoma (46)
Follicular lymphoma stage ii (38)
Follicular lymphoma stage i (34)
Brain neoplasm malignant (31)
Neoplasm malignant (23)
Other Drugs Used for Soft tissue sarcoma
PAZOPANIB (1,400)
DOXORUBICIN (302)
IFOSFAMIDE (237)
CABOZANTINIB S-MALATE (192)
TRABECTEDIN (183)
NIVOLUMAB (156)
OLARATUMAB (156)
IMATINIB (124)
SUNITINIB MALATE (123)
RIPRETINIB (110)